Opinion
There is no "unholy alliance" between doctors and drug, medical firms
LETTER — Posted June 16, 2008
Regarding "Med schools asked to shun drug firm freebies" (Article, May 26): Your front-page article highlights how out of touch the Assn. of American Medical Colleges is with medical practice. As the costs and requirements of continuing medical education escalate, medical and pharmaceutical companies should be allowed to introduce us to new technologies and to conduct seminars on their products without the stigma of conflict of interest.
Today, by far most medical research is being conducted in private industry, not in academia. Our close association with this sector should only serve to benefit society.
It is an assault on my professionalism when they righteously presume that just because a pharmaceutical company sponsors a lecture and treats me to dinner that I will be compelled to use that product against the best interests of my patients.
If a vendor pays for me to fly across the country to observe an expert perform a new surgical procedure, how can that possibly be construed as being a disservice to the people whom I am entrusted to treat? And why shouldn't I be allowed to declare that as a credit toward my continuing medical education requirement? What could be more in keeping with the spirit of continuing education?
It's about time to expunge this ill-conceived notion that doctors and the medical and pharmaceutical companies have an unholy alliance, and the AMA should lead the way in repairing our tarnished ethical image.
Ronald Ripps, MD, Danbury, Conn.
Note: This item originally appeared at http://www.ama-assn.org/amednews/2008/06/16/edlt0616.htm.












